Virus-like particles (VLPs) are nanoscale particles, approximately 100–300 nm in diameter, formed by self-assembly of viral capsid proteins, which lack viral genetic material, cannot replicate ...

Novavax And The NIH Agree To Evaluate A Virus-like Particle (VLP) Vaccine Candidate Against The Novel Influenza A (H1N1) Virus Novavax, Inc. (Nasdaq: NVAX) and the Division of Microbiology and ...

VLP stands for virus-like particles. Virus-like particles are molecules that mimic viruses but are not infectious. They are a very effective way of creating vaccines against diseases such as human ...

QUEBEC CITY, Jan. 5 /PRNewswire-FirstCall/ - Medicago Inc. (TSX: MDG) a biotechnology company focused on developing highly effective and affordable vaccines based on ...

Immunization of indolent non-Hodgkin’s lymphoma patients with autologous monocyte-derived dendritic cells loaded with heat shocked and killed autologous tumor cells: A phase I study This is an ASCO ...